DOCSLIB.ORG

Host Immune Defense Upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions As Drivers of Inflammatory Responses

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Host Immune Defense Upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions As Drivers of Inflammatory Responses Journal of Fungi Review Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses Dolly E. Montaño 1,2 and Kerstin Voigt 1,2,* 1 Jena Microbial Resource Collection, Leibniz Institute for Natural Product Research and Infection Biology—Hans Knöll Institute (HKI), 07745 Jena, Germany; [email protected] 2 Institute of Microbiology, Friedrich Schiller University Jena, 07743 Jena, Germany * Correspondence: [email protected]; Tel.: +49-3641-532-1395 Received: 14 August 2020; Accepted: 15 September 2020; Published: 17 September 2020 Abstract: During the last few decades, mucormycosis has emerged as one of the most common fungal infections, following candidiasis and aspergillosis. The fungal order responsible for causing mucormycosis is the Mucorales. The main hallmarks of this infection include the invasion of blood vessels, infarction, thrombosis, and tissue necrosis, which are exhibited at the latest stages of the infection. Therefore, the diagnosis is often delayed, and the rapid progression of the infection severely endangers the life of people suffering from diabetes mellitus, hematological malignancies, or organ transplantation. Given the fact that mortality rates for mucormycosis range from 40 to 80%, early diagnosis and novel therapeutic strategies are urgently needed to battle the infection. However, compared to other fungal infections, little is known about the host immune response against Mucorales and the influence of inflammatory processes on the resolution of the infection. Hence, in this review, we summarized our current understanding of the interplay among pro-inflammatory cytokines, chemokines, and the host-immune cells in response to mucoralean fungi, as well as their potential use for immunotherapies. Keywords: zygomycosis; phagocytosis; phagocytes; macrophages; monocytes; epi- and endothelium; Mucoromycotina; Rhizopus; Rhizomucor; Mucor; Lichtheimia; innate immune system 1. Introduction The life-threatening infection mucormycosis is currently the third most common invasive fungal infection [1,2]. Most of the incidences occur in patients with diabetes mellitus, hematological malignancies, organ transplantation, and in few cases also in immunocompetent individuals [1–4]. Mucormycosis is caused by fungi belonging to the order Mucorales, mainly by Rhizopus, Mucor, and Lichtheimia (ex Absidia) species (Figure1)[ 5,6]. This infection is characterized by a fast invasion of blood vessels that further leads to infarction, thrombosis, and tissue necrosis. As a consequence, most of the patients suffer devastating results, such as massive removal of infected tissue, loss of organ functionality, and death in the worse scenario [7,8]. Contrary to candidiasis and invasive aspergillosis, mucormycosis cases are normally diagnosed in advanced stages of the infection. Furthermore, treatments against this infection are limited to liposomal amphotericin B, isavuconazole, and posaconazole, which represents a disadvantage in the case of antifungal drug resistance [5,9]. Although mucormycosis has become an emerging fungal infection, compared to the most common fungal invasive infections, aspergillosis and candidiasis, little is known about the host immune response against Mucorales [4,10]. Hence, understanding the molecular mechanisms involved in the recognition and immune response to Mucorales could provide novel insights for antifungal therapies and diagnosis. J. Fungi 2020, 6, 173; doi:10.3390/jof6030173 www.mdpi.com/journal/jof J. Fungi 2020, 6, 173 2 of 14 Therefore,J. Fungi in this 2020, review,6, x FOR PEER we REVIEW will summarize our current understanding of the molecular2 of interaction15 among host cells in response to mucoralean fungi. In particular, we will focus on the production of involved in the recognition and immune response to Mucorales could provide novel insights for cytokinesantifungal and chemokines, therapies and which diagnosis. enables Therefore, communication in this review, among we leukocytes,will summarize and our plays current an essential role in theunderstanding regulation ofof ditheff erentmolecular cellular interaction processes among during host cells infection, in response such to mucoralean as phagocytes fungi. recruitment, In inflammation,particular, antigen we presentation,will focus on activation,the production and immuneof cytokines cell maturationand chemokines, [11]. which Moreover, enables during this review, wecommunication will emphasize among three leukocytes, relevant and plays aspects an essentia of thel hostrole in response the regulation upon of Mucoraleandifferent cellular infections: processes during infection, such as phagocytes recruitment, inflammation, antigen presentation, (i) the cytokineactivation, profile and immune produced cell maturation by immune [11]. Moreov cells iner, responseduring this toreview, Mucorales. we will emphasize (ii) The three influence of cytokinesrelevant and chemokines aspects of the onhost the response activation upon Mucoralean of adaptive infections: immune i) the cells. cytokine (iii) profile The potential produced usage of cytokinesby as immune an adjuvant cells in forresponse immunotherapies to Mucorales. ii) during The influence invasive of cytokines mucormycosis. and chemokines We will on notthe address virulenceactivation factors andof adaptive specific immune cell-mediated cells. iii) The response potential to usage Mucorales, of cytokines since as thesean adjuvant topics for have been immunotherapies during invasive mucormycosis. We will not address virulence factors and specific previously summarized [12,13]. cell-mediated response to Mucorales, since these topics have been previously summarized [12,13]. Figure 1.FigureThe most 1. The common most common pathogenic pathogenic mucoralean mucoralean fungi fungi.. RhizopusRhizopus oryzae oryzae (syn.: (syn.:RhizopusRhizopus arrhizus), arrhizus), Mucor circinelloides, and Lichtheimia corymbifera are the most frequently reported causative agents of Mucor circinelloides, and Lichtheimia corymbifera are the most frequently reported causative agents mucormycosis. The left panel depicts the colony morphologies of four-week-old R. oryzae and L. of mucormycosis.corymbifera cultivated The left on panel malt depictsextract agar, the as colony well as morphologiesthe colony morphology of four-week-old of one-week-oldR. M. oryzae and L. corymbiferacircinelloidescultivated cultivated on malton potato extract dextrose agar, agar. as wellThe asright the panel colony represents morphology the corresponding of one-week-old M. circinelloidesmicromorphologiescultivated including on potato spor dextroseangia (marked agar. with The arrows), right in panel which representsthe sporangiospores the corresponding are micromorphologiesproduced. Sporangium including of R. sporangia oryzae presents (marked a dark-brown with coloration, arrows), while in which M. circinelloides the sporangiospores exhibits a are yellow color and L. corymbifera a dark grey pigmentation. produced. Sporangium of R. oryzae presents a dark-brown coloration, while M. circinelloides exhibits a yellow color and L. corymbifera a dark grey pigmentation. 2. Inflammation in Antifungal Response Inflammation has been traditionally defined according to its main features: redness, warmth, pain, and swelling. However, one of the latest definition of inflammation includes its protective role in response to invading pathogens or endogenous signals, resulting in the elimination of the initial cause of injury, clearance, and tissue repair [14]. Furthermore, the activation and resolution of the inflammatory response are strictly regulated to protect the organism from collateral damages. In this regard, specialized cell-surface receptors known as pattern-recognition receptors (PRRs) activate J. Fungi 2020, 6, 173 3 of 14 inflammatory cascades upon the recognition of pathogen-associated molecular patterns (PAMPs) or endogenous signals, such as damage-associated molecular patterns (DAMPs) [15]. Consequently, activation of PRRs triggers the release of proinflammatory cytokines and chemokines—which are secreted proteins that exert further pro-inflammatory cascades and recruit additional immune cells to the site of infection [11]. In the case of an antifungal inflammatory-mediated response, PRRs of the host-cells recognize conserved microbial structures known as microbial associated molecular patterns (MAMPs), which are mainly found in the fungal cell-wall and comprise β-1,3-glucan, chitin, mannans, mannoproteins, and unmethylated DNA [16]. Furthermore, fungal growth and invasion by pathogenic fungi also induce local damage, promoting the release of DAMPs and amplifying the inflammatory response [17]. 3. Clinical Features of Inflammation in Mucormycosis Angioinvasion, thrombosis, and tissue necrosis are the most common hallmarks of mucormycosis [7]. However, inflammatory responses accompanied by these hallmarks have not been widely characterized in clinical trials. A study by Ben-Ami et al. analyzed histopathologic features in cancer patients diagnosed with pulmonary mucormycosis (PM). The authors found that 100% of the patients with PM showed angioinvasion; on the contrary, only 30% of the patients exhibited inflammatory infiltrates, such as aggregates of macrophages in the margin of necrotic tissues [18]. Furthermore, patients within the same cohort that underwent allogeneic hematopoietic stem cell transplantation (HSCT) had more inflammatory cell infiltration compared to non-HSCT patients
Load more

Recommended publications
  • Isolation and Expression of a Malassezia Globosa Lipase Gene, LIP1 Yvonne M
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector ORIGINAL ARTICLE Isolation and Expression of a Malassezia globosa Lipase Gene, LIP1 Yvonne M. DeAngelis1, Charles W. Saunders1, Kevin R. Johnstone1, Nancy L. Reeder1, Christal G. Coleman2, Joseph R. Kaczvinsky Jr1, Celeste Gale1, Richard Walter1, Marlene Mekel1, Martin P. Lacey1, Thomas W. Keough1, Angela Fieno1, Raymond A. Grant1, Bill Begley1, Yiping Sun1, Gary Fuentes1, R. Scott Youngquist1, Jun Xu1 and Thomas L. Dawson Jr1 Dandruff and seborrheic dermatitis (D/SD) are common hyperproliferative scalp disorders with a similar etiology. Both result, in part, from metabolic activity of Malassezia globosa and Malassezia restricta, commensal basidiomycete yeasts commonly found on human scalps. Current hypotheses about the mechanism of D/SD include Malassezia-induced fatty acid metabolism, particularly lipase-mediated breakdown of sebaceous lipids and release of irritating free fatty acids. We report that lipase activity was detected in four species of Malassezia, including M. globosa. We isolated lipase activity by washing M. globosa cells. The isolated lipase was active against diolein, but not triolein. In contrast, intact cells showed lipase activity against both substrates, suggesting the presence of at least another lipase. The diglyceride-hydrolyzing lipase was purified from the extract, and much of its sequence was determined by peptide sequencing. The corresponding lipase gene (LIP1) was cloned and sequenced. Confirmation that LIP1 encoded a functional lipase was obtained using a covalent lipase inhibitor. LIP1 was differentially expressed in vitro. Expression was detected on three out of five human scalps, as indicated by reverse transcription-PCR.
    [Show full text]
  • Fungi-Rhizopus
    Characters of Fungi Some of the most important characters of fungi are as follows: 1. Occurrence 2. Thallus organization 3. Different forms of mycelium 4. Cell structure 5. Nutrition 6. Heterothallism and Homothallism 7. Reproduction 8. Classification of Fungi. 1. Occurrence: Fungi are cosmopolitan and occur in air, water soil and on plants and animals. They prefer to grow in warm and humid places. Hence, we keep food in the refrigerator to prevent bacterial and fungal infestation. 2. Thallus organization: Except some unicellular forms (e.g. yeasts, Synchytrium), the fungal body is a thallus called mycelium. The mycelium is an interwoven mass of thread-like hyphae (Sing, hypha). Hyphae may be septate (with cross wall) and aseptate (without cross wall). Some fungi are dimorphic that found as both unicellular and mycelial forms e.g. Candida albicans. 3. Different forms of mycelium: (a) Plectenchyma (fungal tissue): In a fungal mycelium, hyphae organized loosely or compactly woven to form a tissue called plectenchyma. It is two types: i. Prosenchyma or Prosoplectenchyma: In these fungal tissue hyphae are loosely interwoven lying more or less parallel to each other. ii. Pseudoparenchyma or paraplectenchyma: In these fungal tissue hyphae are compactly interwoven looking like a parenchyma in cross-section. (b) Sclerotia (Gr. Skleros=haid): These are hard dormant bodies consist of compact hyphae protected by external thickened hyphae. Each Sclerotium germinates into a mycelium, on return of favourable condition, e.g., Penicillium. (c) Rhizomorphs: They are root-like compactly interwoven hyphae with distinct growing tip. They help in absorption and perennation (to tide over the unfavourable periods), e.g., Armillaria mellea.
    [Show full text]
  • Estimated Burden of Fungal Infections in Oman
    Journal of Fungi Article Estimated Burden of Fungal Infections in Oman Abdullah M. S. Al-Hatmi 1,2,3,* , Mohammed A. Al-Shuhoumi 4 and David W. Denning 5 1 Department of microbiology, Natural & Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman 2 Department of microbiology, Centre of Expertise in Mycology Radboudumc/CWZ, 6500 Nijmegen, The Netherlands 3 Foundation of Atlas of Clinical Fungi, 1214GP Hilversum, The Netherlands 4 Ibri Hospital, Ministry of Health, Ibri 115, Oman; [email protected] 5 Manchester Fungal Infection Group, Manchester Academic Health Science Centre, The University of Manchester, Manchester M13 9PL, UK; [email protected] * Correspondence: [email protected]; Tel.: +968-25446328; Fax: +968-25446612 Abstract: For many years, fungi have emerged as significant and frequent opportunistic pathogens and nosocomial infections in many different populations at risk. Fungal infections include disease that varies from superficial to disseminated infections which are often fatal. No fungal disease is reportable in Oman. Many cases are admitted with underlying pathology, and fungal infection is often not documented. The burden of fungal infections in Oman is still unknown. Using disease frequencies from heterogeneous and robust data sources, we provide an estimation of the incidence and prevalence of Oman’s fungal diseases. An estimated 79,520 people in Oman are affected by a serious fungal infection each year, 1.7% of the population, not including fungal skin infections, chronic fungal rhinosinusitis or otitis externa. These figures are dominated by vaginal candidiasis, followed by allergic respiratory disease (fungal asthma). An estimated 244 patients develop invasive aspergillosis and at least 230 candidemia annually (5.4 and 5.0 per 100,000).
    [Show full text]
  • A Newly Isolated Rhizopus Microsporus Var. Chinensis Capable of Secreting Amyloytic Enzymes with Raw-Starch-Digesting Activity
    J. Microbiol. Biotechnol. (2010), 20(2), 383–390 doi: 10.4014/jmb.0907.07025 First published online 24 December 2009 A Newly Isolated Rhizopus microsporus var. chinensis Capable of Secreting Amyloytic Enzymes with Raw-Starch-Digesting Activity Li, Yu-Na1,2, Gui-Yang Shi1,2, Wu Wang1,2*, and Zheng-Xiang Wang1,2* 1The Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi 214122, China 2Research Center of Bio-resource and Bio-energy, School of Bioengineering, Jiangnan University, Wuxi 214122, China Received: July 19, 2009 / Revised: November 15, 2009 / Accepted: November 17, 2009 A newly isolated active producer of raw-starch-digesting are available, but researchers continue to search for new amyloytic enzymes, Rhizopus microsporus var. chinensis amyloytic enzymes that could create new applications. CICIM-CU F0088, was screened and identified by The traditional course of enzymatic starch saccharification morphological characteristics and molecular phylogenetic is a high-energy-consumption procedure, which significantly analyses. This fungus was isolated from the soil of Chinese enhances the cost of starch-related products. Therefore, to glue pudding mill, and produced high levels of amylolytic reduce the cost of starch processing, the importance of activity under solid-state fermentation with supplementation enzymatic saccharification of raw starch without cooking of starch and wheat bran. Results of thin-layer chromatography has become well recognized recently [24, 34]. This has showed there are two kinds of amyloytic enzymes formed generated a worldwide interest in the discovery of several by this strain, including one α-amylase and two glucoamylases. raw-starch-digesting amyloytic enzymes that do not require It was found in the electron microscope experiments that gelatinization and can directly hydrolyze the raw starch in the two glucoamylases can digest raw corn starch and a single step [26, 34].
    [Show full text]
  • Distribution of Methionine Sulfoxide Reductases in Fungi and Conservation of the Free- 2 Methionine-R-Sulfoxide Reductase in Multicellular Eukaryotes
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.26.433065; this version posted February 27, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Distribution of methionine sulfoxide reductases in fungi and conservation of the free- 2 methionine-R-sulfoxide reductase in multicellular eukaryotes 3 4 Hayat Hage1, Marie-Noëlle Rosso1, Lionel Tarrago1,* 5 6 From: 1Biodiversité et Biotechnologie Fongiques, UMR1163, INRAE, Aix Marseille Université, 7 Marseille, France. 8 *Correspondence: Lionel Tarrago ([email protected]) 9 10 Running title: Methionine sulfoxide reductases in fungi 11 12 Keywords: fungi, genome, horizontal gene transfer, methionine sulfoxide, methionine sulfoxide 13 reductase, protein oxidation, thiol oxidoreductase. 14 15 Highlights: 16 • Free and protein-bound methionine can be oxidized into methionine sulfoxide (MetO). 17 • Methionine sulfoxide reductases (Msr) reduce MetO in most organisms. 18 • Sequence characterization and phylogenomics revealed strong conservation of Msr in fungi. 19 • fRMsr is widely conserved in unicellular and multicellular fungi. 20 • Some msr genes were acquired from bacteria via horizontal gene transfers. 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.26.433065; this version posted February 27, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]
  • Oral Candidiasis: a Review
    International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 2, Issue 4, 2010 Review Article ORAL CANDIDIASIS: A REVIEW YUVRAJ SINGH DANGI1, MURARI LAL SONI1, KAMTA PRASAD NAMDEO1 Institute of Pharmaceutical Sciences, Guru Ghasidas Central University, Bilaspur (C.G.) – 49500 Email: [email protected] Received: 13 Jun 2010, Revised and Accepted: 16 July 2010 ABSTRACT Candidiasis, a common opportunistic fungal infection of the oral cavity, may be a cause of discomfort in dental patients. The article reviews common clinical types of candidiasis, its diagnosis current treatment modalities with emphasis on the role of prevention of recurrence in the susceptible dental patient. The dental hygienist can play an important role in education of patients to prevent recurrence. The frequency of invasive fungal infections (IFIs) has increased over the last decade with the rise in at‐risk populations of patients. The morbidity and mortality of IFIs are high and management of these conditions is a great challenge. With the widespread adoption of antifungal prophylaxis, the epidemiology of invasive fungal pathogens has changed. Non‐albicans Candida, non‐fumigatus Aspergillus and moulds other than Aspergillus have become increasingly recognised causes of invasive diseases. These emerging fungi are characterised by resistance or lower susceptibility to standard antifungal agents. Oral candidiasis is a common fungal infection in patients with an impaired immune system, such as those undergoing chemotherapy for cancer and patients with AIDS. It has a high morbidity amongst the latter group with approximately 85% of patients being infected at some point during the course of their illness. A major predisposing factor in HIV‐infected patients is a decreased CD4 T‐cell count.
    [Show full text]
  • Review Article Sporotrichosis: an Overview and Therapeutic Options
    Hindawi Publishing Corporation Dermatology Research and Practice Volume 2014, Article ID 272376, 13 pages http://dx.doi.org/10.1155/2014/272376 Review Article Sporotrichosis: An Overview and Therapeutic Options Vikram K. Mahajan Department of Dermatology, Venereology & Leprosy, Dr. R. P. Govt. Medical College, Kangra, Tanda, Himachal Pradesh 176001, India Correspondence should be addressed to Vikram K. Mahajan; [email protected] Received 30 July 2014; Accepted 12 December 2014; Published 29 December 2014 Academic Editor: Craig G. Burkhart Copyright © 2014 Vikram K. Mahajan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Sporotrichosis is a chronic granulomatous mycotic infection caused by Sporothrix schenckii, a common saprophyte of soil, decaying wood, hay, and sphagnum moss, that is endemic in tropical/subtropical areas. The recent phylogenetic studies have delineated the geographic distribution of multiple distinct Sporothrix species causing sporotrichosis. It characteristically involves the skin and subcutaneous tissue following traumatic inoculation of the pathogen. After a variable incubation period, progressively enlarging papulo-nodule at the inoculation site develops that may ulcerate (fixed cutaneous sporotrichosis) or multiple nodules appear proximally along lymphatics (lymphocutaneous sporotrichosis). Osteoarticular sporotrichosis or primary pulmonary sporotrichosis are rare and occur from direct inoculation or inhalation of conidia, respectively. Disseminated cutaneous sporotrichosis or involvement of multiple visceral organs, particularly the central nervous system, occurs most commonly in persons with immunosuppression. Saturated solution of potassium iodide remains a first line treatment choice for uncomplicated cutaneous sporotrichosis in resource poor countries but itraconazole is currently used/recommended for the treatment of all forms of sporotrichosis.
    [Show full text]
  • Antifungals for Onychomycosis & Systemic Infections
    Clinical Policy: Infectious Disease Agents: Antifungals for Onychomycosis & Systemic Infections Reference Number: OH.PHAR.PPA.70 Effective Date: 01/01/2020 Last Review Date: N/A Coding Implications Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description: INFECTIOUS DISEASE AGENTS: AGENTS FOR ONYCHOMYCOSIS NO PA REQUIRED “PREFERRED” PA REQUIRED “NON-PREFERRED” GRIFULVIN®V tablets (griseofulvin, microsize) ITRACONAZOLE (generic of Sporanox®) GRISEOFULVIN suspension (generic of LAMISIL Granules (terbinafine) Grifulvin®V) ONMEL® (itraconazole) GRIS-PEG® (griseofulvin, ultramicrosize) SPORANOX® 100mg/10ml oral solution TERBINAFINE (generic of Lamisil®) (itraconazole) INFECTIOUS DISEASE AGENTS: AGENTS FOR SYSTEMIC INFECTIONS NO PA REQUIRED “PREFERRED” PA REQUIRED “NON-PREFERRED” FLUCONAZOLE (generic of Diflucan®) CRESEMBA® (isavuconazonium) FLUCONAZOLE suspension (generic of ITRACONAZOLE capsules (generic of Diflucan®) Sporanox®) FLUCYTOSINE (generic of Ancobon®) NOXAFIL® (posaconazole) KETOCONAZOLE (generic of Nizoral®) ORAVIG® (miconazole) SPORANOX® 100mg/10ml oral solution (itraconazole) VORICONAZOLE (generic of Vfend®) TOLSURA (itraconazole) FDA Approved Indication(s): Antifungals are indicated for the treatment of: • aspergillosis • blastomycosis • bone and joint infections • candidemia • candidiasis • candidiasis prophylaxis • candiduria • cryptococcal meningitis • cryptococcosis • cystitis Page 1 of 9 CLINICAL POLICY Infectious Disease Agents:
    [Show full text]
  • Isolation of an Emerging Thermotolerant Medically Important Fungus, Lichtheimia Ramosa from Soil
    Vol. 14(6), pp. 237-241, June, 2020 DOI: 10.5897/AJMR2020.9358 Article Number: CC08E2B63961 ISSN: 1996-0808 Copyright ©2020 Author(s) retain the copyright of this article African Journal of Microbiology Research http://www.academicjournals.org/AJMR Full Length Research Paper Isolation of an emerging thermotolerant medically important Fungus, Lichtheimia ramosa from soil Imade Yolanda Nsa*, Rukayat Odunayo Kareem, Olubunmi Temitope Aina and Busayo Tosin Akinyemi Department of Microbiology, Faculty of Science, University of Lagos, Nigeria. Received 12 May, 2020; Accepted 8 June, 2020 Lichtheimia ramosa, a ubiquitous clinically important mould was isolated during a screen for thermotolerant fungi obtained from soil on a freshly burnt field in Ikorodu, Lagos State. In the laboratory, as expected it grew more luxuriantly on Potato Dextrose Agar than on size limiting Rose Bengal Agar. The isolate had mycelia with a white cottony appearance on both media. It was then identified based on morphological appearance, microscopy and by fungal Internal Transcribed Spacer ITS-5.8S rDNA sequencing. This might be the first report of molecular identification of L. ramosa isolate from soil in Lagos, as previously documented information could not be obtained. Key words: Soil, thermotolerant, Lichtheimia ramosa, Internal Transcribed Spacer (ITS). INTRODUCTION Zygomycetes of the order Mucorales are thermotolerant L. ramosa is abundant in soil, decaying plant debris and moulds that are ubiquitous in nature (Nagao et al., 2005). foodstuff and is one of the causative agents of The genus Lichtheimia (syn. Mycocladus, Absidia) mucormycosis in humans (Barret et al., 1999). belongs to the Zygomycete class and includes Mucormycosis is an opportunistic invasive infection saprotrophic microorganisms that can be isolated from caused by Lichtheimia, Mucor, and Rhizopus of the order decomposing soil and plant material (Alastruey-Izquierdo Mucorales.
    [Show full text]
  • Managing Athlete's Foot
    South African Family Practice 2018; 60(5):37-41 S Afr Fam Pract Open Access article distributed under the terms of the ISSN 2078-6190 EISSN 2078-6204 Creative Commons License [CC BY-NC-ND 4.0] © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0 REVIEW Managing athlete’s foot Nkatoko Freddy Makola,1 Nicholus Malesela Magongwa,1 Boikgantsho Matsaung,1 Gustav Schellack,2 Natalie Schellack3 1 Academic interns, School of Pharmacy, Sefako Makgatho Health Sciences University 2 Clinical research professional, pharmaceutical industry 3 Professor, School of Pharmacy, Sefako Makgatho Health Sciences University *Corresponding author, email: [email protected] Abstract This article is aimed at providing a succinct overview of the condition tinea pedis, commonly referred to as athlete’s foot. Tinea pedis is a very common fungal infection that affects a significantly large number of people globally. The presentation of tinea pedis can vary based on the different clinical forms of the condition. The symptoms of tinea pedis may range from asymptomatic, to mild- to-severe forms of pain, itchiness, difficulty walking and other debilitating symptoms. There is a range of precautionary measures available to prevent infection, and both oral and topical drugs can be used for treating tinea pedis. This article briefly highlights what athlete’s foot is, the different causes and how they present, the prevalence of the condition, the variety of diagnostic methods available, and the pharmacological and non-pharmacological management of the
    [Show full text]
  • Mucormycosis of the Central Nervous System
    Journal of Fungi Review Mucormycosis of the Central Nervous System 1 1,2, , 3, , Amanda Chikley , Ronen Ben-Ami * y and Dimitrios P Kontoyiannis * y 1 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 64239, Israel 3 Department of Infectious Diseases, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA * Correspondence: [email protected] (R.B.-A.); [email protected] (D.P.K.) These authors contribute equally to this paper. y Received: 6 June 2019; Accepted: 7 July 2019; Published: 8 July 2019 Abstract: Mucormycosis involves the central nervous system by direct extension from infected paranasal sinuses or hematogenous dissemination from the lungs. Incidence rates of this rare disease seem to be rising, with a shift from the rhino-orbital-cerebral syndrome typical of patients with diabetes mellitus and ketoacidosis, to disseminated disease in patients with hematological malignancies. We present our current understanding of the pathobiology, clinical features, and diagnostic and treatment strategies of cerebral mucormycosis. Despite advances in imaging and the availability of novel drugs, cerebral mucormycosis continues to be associated with high rates of death and disability. Emerging molecular diagnostics, advances in experimental systems and the establishment of large patient registries are key components of ongoing efforts to provide a timely diagnosis and effective treatment to patients with cerebral mucormycosis. Keywords: central nervous system; mucormycosis; Mucorales; zygomycosis 1. Introduction Mucormycosis is the second most frequent invasive mold disease after aspergillosis [1–3], with rising incidence reported in some countries [4–7].
    [Show full text]
  • Oral Antifungals Month/Year of Review: July 2015 Date of Last
    © Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 | Fax 503-947-1119 Class Update with New Drug Evaluation: Oral Antifungals Month/Year of Review: July 2015 Date of Last Review: March 2013 New Drug: isavuconazole (a.k.a. isavunconazonium sulfate) Brand Name (Manufacturer): Cresemba™ (Astellas Pharma US, Inc.) Current Status of PDL Class: See Appendix 1. Dossier Received: Yes1 Research Questions: Is there any new evidence of effectiveness or safety for oral antifungals since the last review that would change current PDL or prior authorization recommendations? Is there evidence of superior clinical cure rates or morbidity rates for invasive aspergillosis and invasive mucormycosis for isavuconazole over currently available oral antifungals? Is there evidence of superior safety or tolerability of isavuconazole over currently available oral antifungals? • Is there evidence of superior effectiveness or safety of isavuconazole for invasive aspergillosis and invasive mucormycosis in specific subpopulations? Conclusions: There is low level evidence that griseofulvin has lower mycological cure rates and higher relapse rates than terbinafine and itraconazole for adult 1 onychomycosis.2 There is high level evidence that terbinafine has more complete cure rates than itraconazole (55% vs. 26%) for adult onychomycosis caused by dermatophyte with similar discontinuation rates for both drugs.2 There is low
    [Show full text]